Area of research
Rheumatology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Chemotherapy and Lung cancer, with related work in Epidermal growth factor receptor, Oncology, Exon. Notable publications include 'Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions', 'Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia...', and 'Amivantamab plus chemotherapy vs chemotherapy as first-line treatment among patients with EGFR exon 20 insertion–mutated advanced non-small cell lung cancer (NSCLC): PAPILLON...'.
Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysis
Amivantamab plus chemotherapy vs chemotherapy as first-line treatment among patients with EGFR exon 20 insertion–mutated advanced non-small cell lung cancer (NSCLC): PAPILLON Chinese subgroup analysis.
Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions